I

Iksuda Therapeutics

31 employees

Iksuda Therapeutics is a biotechnology company specializing in the development of next generation biotherapeutics

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Cancer research

Cancer Treatment

Antibody-Drug Conjugates

Chemistry

Toxins

Conjugation Chemistry

Biopharma

Antibody Drug Conjugate

Drug Discovery

Preclinical

Antibodies

ADC Stability

Organic Synthesis

Bioconjugation

PermaLink™

Cell Biology

Therapeutics

Clinical

Drug Development

ADCs

Licencing

Date founded

2007

Funding rounds raised

Total raised

$47M

from 5 investors over 5 rounds

I

Iksuda Therapeutics raised $47M on June 7, 2021

Investors: Premier Partners and Celltrion Inc.

I

Iksuda Therapeutics raised $1M on July 10, 2013

Investors: THE NORTH EAST TECHNOLOGY FUND L.P.

I

Iksuda Therapeutics raised $3.1M on June 21, 2012

Investors: IP Group plc

I

Iksuda Therapeutics raised $793K on October 9, 2010